Skip to main content

GeneDX CEO Katherine Stueland on AI, Rare Diseases, and Leadership

CNBC TelevisionNovember 5, 202528 min560 views
39 connections·40 entities in this video→

GeneDX's Mission and Achievements

  • 🎯 GeneDX is a leader in genomic testing, focused on diagnosing rare diseases, particularly in children and newborns.
  • πŸ’‘ The company has identified over 400 new disease gene relationships and achieved profitability under Katherine Stueland's leadership.
  • πŸš€ In the past year, GeneDX has focused on innovations in genomic sequencing, accelerating diagnoses, and expanding into pediatric and newborn screening.

Addressing Rare Diseases and Healthcare Challenges

  • πŸ‘Ά One in 10 Americans has a rare disease, with half being children, yet accurate diagnosis often takes an average of five years.
  • πŸ’° GeneDX focuses on areas with dire unmet needs and good reimbursement coverage, such as epilepsy, autism, and developmental delay, to ensure access and profitability.
  • πŸ₯ The company aims to prevent disease progression through earlier diagnosis, reducing the current healthcare system's reactive approach.

Leveraging AI for Diagnosis and Operations

  • 🧠 AI is deployed in three key areas: business operations for gathering patient data, analyzing vast genotypic and phenotypic information, and empowering clinical geneticists.
  • πŸ“Š GeneDX possesses one of the largest rare disease datasets in the US, enriched with genotypic and phenotypic information, which AI can unlock.
  • πŸ§‘β€βš•οΈ AI serves up likely diagnoses, enabling clinical geneticists to make definitive calls, thereby delivering life-changing information to families.

Leadership Journey and Communication Skills

  • 🌟 Katherine Stueland's atypical career path, starting with a personal connection to cystic fibrosis, led her from English literature and communications to leading GeneDX.
  • πŸ—£οΈ Her background in communications allows her to effectively bring together researchers, clinicians, patient advocates, and investors to solve problems.
  • 🀝 Stueland emphasizes listening, curiosity, and preparation as key to effective communication and leadership.

Overcoming Imposter Syndrome and Leading Authentically

  • πŸ’‘ Stueland advises against wasting time on self-doubt, encouraging decisiveness and belief in oneself, especially for women facing imposter syndrome.
  • πŸ’– She advocates for a leadership style that blends authenticity, vulnerability, and courageous decision-making, always centering on the patient.
  • πŸ§˜β€β™€οΈ Life hacks include prioritizing exercise and practicing meditation and breathwork for clarity and energy, alongside her background in yoga and dance.

Impact of Government Funding and Health Economics

  • πŸ‡ΊπŸ‡Έ While not directly reliant on NIH funding, GeneDX highlights the impact of government-funded science and technology, like the Human Genome Project.
  • πŸ’Έ The company generates health economic data demonstrating that earlier diagnosis of rare diseases saves the healthcare system significant dollars by reducing symptom treatment and hospitalizations.
  • 🀝 Stueland learned the importance of trusting her gut instinct after a past misstep involving ignoring a warning sign before issuing company guidance.
Knowledge graph40 entities Β· 39 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
40 entities
Chapters12 moments

Key Moments

Transcript106 segments

Full Transcript

Topics15 themes

What’s Discussed

GeneDXGenomic TestingRare DiseasesArtificial IntelligenceAI in HealthcarePersonalized MedicineEarly DiagnosisGenomic SequencingPediatric ScreeningNewborn ScreeningHealthcare EconomicsLeadershipImposter SyndromeCommunicationsData Analysis
Smart Objects40 Β· 39 links
CompaniesΒ· 4
PeopleΒ· 3
ConceptsΒ· 27
ProductsΒ· 2
EventsΒ· 2
LocationsΒ· 2